欢迎来到天天文库
浏览记录
ID:54984298
大小:219.88 KB
页数:3页
时间:2020-05-07
《AIDS病人接受奈韦拉平治疗的相关肝毒性-论文.pdf》由会员上传分享,免费在线阅读,更多相关内容在应用文档-天天文库。
1、546中国艾滋病性病2013年8月第19卷第8期ChinJAIDSSTDVo1.19No.8Aug.2013AIDS病人接受奈韦拉平治疗的相关肝毒性杨成彬,梁成(布拖县人民医院抗病毒治疗中心,四川凉山616350)摘要:目的了解艾滋病(AIDS)病人接受奈韦拉平(NVP)治疗的相关肝毒性。方法采用回顾性分析的方法,对2005~2011年在布拖县接受抗病毒治疗的AIDS病人,出现3~4级肝毒性的临床资料进行总结和分析。结果接受抗病毒治疗的826例病人中,治疗6个月内出现3~4级肝毒性的22例(2.7%)。基线检查:22例中,丙型
2、肝炎病毒(HCV)抗体阳性16例(72.7%),乙型肝炎病毒表面抗原(HBsAg)阳性12例(54.5),抗一HCV和HBsAg均阳性者8例(36.4);抗一HCV和HBsAg均阴性者2例(9.1%),分别与抗一HCV阳性、HBsAg阳性者比较差异均有统计学意义(P3、9)U/L和(88.89±189.42)~tmol/L,差异有统计学意义(P4、sisofhepatotoxicityinAIDSpatientstakingnevirapineYANGCheng—bin,LIANGCheng(AntiviralTreat—mentCenterofthePeople’5HospitalofButuoCounty,Liangshan616350,SichuanProvince,China)Abstract:ObjectiveToanalyzethehepatotoxicityinacquiredimmunedeficiencysyndrome(AIDS)patientsta5、kingnevirapine(NVP).MethodsT0retr0spective1yanalyzeandsummarizetheclinica1dataofA1DSpatientsre—ceivingantivira1treatmentatAntivira1TreatmentCenterofthePeople’sHospita1ofButuoCountywith3to41eve1hepatotoxicityappearedfrom2005to2011.ResultsTotally826AIDSpatientsreceive6、dtheantivira1treatment.Within6monthsafterthetreatment,3to41eve1hepatotoxicityoccurredin22cases(2.7).0fthe22eases,16(72.7)caseswerehepatitisCvirus(HCV)positive,12(54.5%)caseswerehepatitisBvirussurfaceantigen(HBsAg)positive,eight(36.4)caseswereHBsAgandHCV-Agpositives,7、2cases(9.1)wereHBsAgandHCV-Agnegatives.Comparingthetwonegativecaseswiththeother20cases,statisticaldifferencewasfound(尸8、ntiretrovira1treatment.BothALTandTBILrosewithin6monthsafterthetreatment.Comparingwiththebaseline,ALTandTBILincreasedaveragely(281.67-4-213
3、9)U/L和(88.89±189.42)~tmol/L,差异有统计学意义(P4、sisofhepatotoxicityinAIDSpatientstakingnevirapineYANGCheng—bin,LIANGCheng(AntiviralTreat—mentCenterofthePeople’5HospitalofButuoCounty,Liangshan616350,SichuanProvince,China)Abstract:ObjectiveToanalyzethehepatotoxicityinacquiredimmunedeficiencysyndrome(AIDS)patientsta5、kingnevirapine(NVP).MethodsT0retr0spective1yanalyzeandsummarizetheclinica1dataofA1DSpatientsre—ceivingantivira1treatmentatAntivira1TreatmentCenterofthePeople’sHospita1ofButuoCountywith3to41eve1hepatotoxicityappearedfrom2005to2011.ResultsTotally826AIDSpatientsreceive6、dtheantivira1treatment.Within6monthsafterthetreatment,3to41eve1hepatotoxicityoccurredin22cases(2.7).0fthe22eases,16(72.7)caseswerehepatitisCvirus(HCV)positive,12(54.5%)caseswerehepatitisBvirussurfaceantigen(HBsAg)positive,eight(36.4)caseswereHBsAgandHCV-Agpositives,7、2cases(9.1)wereHBsAgandHCV-Agnegatives.Comparingthetwonegativecaseswiththeother20cases,statisticaldifferencewasfound(尸8、ntiretrovira1treatment.BothALTandTBILrosewithin6monthsafterthetreatment.Comparingwiththebaseline,ALTandTBILincreasedaveragely(281.67-4-213
4、sisofhepatotoxicityinAIDSpatientstakingnevirapineYANGCheng—bin,LIANGCheng(AntiviralTreat—mentCenterofthePeople’5HospitalofButuoCounty,Liangshan616350,SichuanProvince,China)Abstract:ObjectiveToanalyzethehepatotoxicityinacquiredimmunedeficiencysyndrome(AIDS)patientsta
5、kingnevirapine(NVP).MethodsT0retr0spective1yanalyzeandsummarizetheclinica1dataofA1DSpatientsre—ceivingantivira1treatmentatAntivira1TreatmentCenterofthePeople’sHospita1ofButuoCountywith3to41eve1hepatotoxicityappearedfrom2005to2011.ResultsTotally826AIDSpatientsreceive
6、dtheantivira1treatment.Within6monthsafterthetreatment,3to41eve1hepatotoxicityoccurredin22cases(2.7).0fthe22eases,16(72.7)caseswerehepatitisCvirus(HCV)positive,12(54.5%)caseswerehepatitisBvirussurfaceantigen(HBsAg)positive,eight(36.4)caseswereHBsAgandHCV-Agpositives,
7、2cases(9.1)wereHBsAgandHCV-Agnegatives.Comparingthetwonegativecaseswiththeother20cases,statisticaldifferencewasfound(尸8、ntiretrovira1treatment.BothALTandTBILrosewithin6monthsafterthetreatment.Comparingwiththebaseline,ALTandTBILincreasedaveragely(281.67-4-213
8、ntiretrovira1treatment.BothALTandTBILrosewithin6monthsafterthetreatment.Comparingwiththebaseline,ALTandTBILincreasedaveragely(281.67-4-213
此文档下载收益归作者所有